Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

gallium Ga 68-NOTA-anti-MMR-VHH2 nanobody

A radiotracer composed of a nanobody against the macrophage mannose receptor (MMR, CD206) conjugated with the bifunctional, macrocyclic chelating agent 1,4,7-triazacyclononane-N,N',N''-triacetic acid (NOTA) and labeled with the radionuclide gallium Ga 68, with potential imaging activity using positron emission tomography (PET). Upon administration, the nanobody moiety of gallium Ga 68-NOTA-anti-MMR-VHH2 nanobody binds to MMR on tumor-associated macrophages (TAMs). Upon PET imaging, MMR-expressing TAMs can be visualized. MMR-expressing TAMs play a role in tumor growth and metastasis as well as immunotherapy resistance.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:68Ga-NOTA-MMR-VHH2 nanobody
68GaNOTA-anti-MMR-VHH2
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search